Gurka et al. [106] designed a dual targeting system in mesoporous silica nanoparticle (MSN) in the adventure of pancreatic cancer treatment, taking advantage of the overexpressed tumor receptor urokinase plasminogen activator receptor (UPAR) as well as the acid tumor microenvironment. Here, PLAUR is linked to pancreatic neoplasm.